CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance. - Watterson A; Picco G; Veninga V; Samarakoon Y; Cattaneo CM; Vieira SF; Karakoc E; Bhosle S; Battaglia TW; Consonni S; Halim TYF; Voest EE; et al. (Cell reports. Medicine, 2026)